MAPT and Alzheimer disease: It is of particular interest that many proteins other than Aβ1-42 and hP-tau contribute early in the formation and cohesion of aggregates, and thus offer promising targets for disruption of pathogenic aggregation in the initial phases of AD and other neurodegenerative diseases.